ROMANISE MCSWAIN: Open Payments
NPI 1003550211 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$174 in 7 payments from 5 companies in 2025. Trend: 2023 $37 · 2024 $157 · 2025 $174
Food & beverage: $174
| Company | Payments | Amount |
|---|---|---|
| Shionogi Inc | 2 | $48 |
| Gilead Sciences, Inc. | 2 | $48 |
| Merck Sharp & Dohme LLC | 1 | $32 |
| ABBVIE INC. | 1 | $24 |
| ViiV Healthcare Company | 1 | $23 |
Products named: Fetroja, ZERBAXA, DALVANCE, CABENUVA.
Industry payments across FL — which companies pay providers there.
